Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (192) Mesothelioma
...CenterWatch: Clinical Trials in Category (192) Mesothelioma Mesothelioma State • Pennsylvania • Texas Country • [X]   Australia • [X]   Belgium • [X]   Brazil • [X]   Germany • [X]   Netherlands • [X ...
View Page

2.  Study Posting (695) Trial #10085, Mesothelioma, Houston, TX
...Study Posting (695) Trial #10085, Mesothelioma, Houston, TX Trial Information Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma Provide the treatment for incurable mesothelioma. Evaluate the adverse effects and tolerance of Antineoplaston A10 ...
View Page

3.  Study Posting (4406) Trial #92726, Mesothelioma, New York, NY
...Study Posting (4406) Trial #92726, Mesothelioma, New York, NY Trial Information A phase II trial of cisplatin, pemetrexed and bevacizumab in untreated malignant mesothelioma The primary objective of this phase II trial in mesothelioma is to evaluate the activity ...
View Page

4.  Study Posting (180) Trial #27700, Mesothelioma, New York, NY
...Study Posting (180) Trial #27700, Mesothelioma, New York, NY Trial Information Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma. Patients will be adults who have histologically confirmed malignant abdominal mesothelioma and will have received ...
View Page

5.  Study Posting (180) Trial #42432, Mesothelioma, New York, NY
...Study Posting (180) Trial #42432, Mesothelioma, New York, NY Trial Information Open - Label Study of Alimta (pemetrexed) Combination with Cisplatin for Chemonaive Patients with Malignant Pleural Mesothelioma. Study Description The purpose of this protocol is to extend the clinical experience with ALIMTA ...
View Page

6.  Study Posting (4406) Trial #92728, Mesothelioma, New York, NY
...Study Posting (4406) Trial #92728, Mesothelioma, New York, NY Trial Information Oxaliplatin (ELOXATIN®) Plus Gemcitabine as First or Second-line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma. A Phase II Clinical Trial The primary goal of this study is to determine the ...
View Page

7.  Study Posting (5265) Trial #147142, Mesothelioma, Sollentuna, Sweden
...Study Posting (5265) Trial #147142, Mesothelioma, Sollentuna, Sweden Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

8.  Study Posting (5265) Trial #147140, Mesothelioma, Madrid, Spain
...Study Posting (5265) Trial #147140, Mesothelioma, Madrid, Spain Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

9.  Study Posting (5265) Trial #147136, Mesothelioma, Haarlem, Netherlands
...Study Posting (5265) Trial #147136, Mesothelioma, Haarlem, Netherlands Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

10.  Study Posting (5265) Trial #147134, Mesothelioma, Haar, Germany
...Study Posting (5265) Trial #147134, Mesothelioma, Haar, Germany Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

11.  Study Posting (5265) Trial #147130, Mesothelioma, Bruxelles, Belgium
...Study Posting (5265) Trial #147130, Mesothelioma, Bruxelles, Belgium Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

12.  Study Posting (5265) Trial #147126, Mesothelioma, Austin, TX
...Study Posting (5265) Trial #147126, Mesothelioma, Austin, TX Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

13.  Study Posting (5265) Trial #147124, Mesothelioma, Pittsburgh, PA
...Study Posting (5265) Trial #147124, Mesothelioma, Pittsburgh, PA Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

14.  Study Posting (5265) Trial #147144, Mesothelioma, Hoddesdon, United Kingdom
...Study Posting (5265) Trial #147144, Mesothelioma, Hoddesdon, United Kingdom Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

15.  Study Posting (5265) Trial #147138, Mesothelioma, Auckland, New Zealand
...Study Posting (5265) Trial #147138, Mesothelioma, Auckland, New Zealand Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

16.  Study Posting (5265) Trial #147132, Mesothelioma, Sao Paulo, Brazil
...Study Posting (5265) Trial #147132, Mesothelioma, Sao Paulo, Brazil Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

17.  Study Posting (5265) Trial #147128, Mesothelioma, South Granville, Australia
...Study Posting (5265) Trial #147128, Mesothelioma, South Granville, Australia Trial Information A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy This is a Phase III a study which incorporates an ...
View Page

18.  Study Posting (4406) Trial #92729, Peritoneal Cancer, New York, NY
...Plus Gemcitabine as First or Second-line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma. A Phase II Clinical Trial The primary goal of this study is to determine the objective tumor response rate for Oxaliplatin plus gemcitabine in patients with malignant pleural mesothelioma and/or malignant peritoneal mesothelioma who have no more than one prior chemotherapy regimen and ...
View Page

19.  CenterWatch: Clinical Trials in Category (773) Pleural Diseases
...Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy Texas Austin : Merck A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy Australia South Granville : Merck A Phase III, Randomized, Double-Blind ...
View Page

20.  Study Posting (2246) Trial #133428, Lung Cancer, Duarte, CA
...65 NCI #7103: A Phase II Study of AZD2171 (NSC #732208)in Patients with Malignant Mesothelioma You have been asked to participate in this research study because you have advanced malignant mesothelioma, a cancer of the lining around the lungs, abdomen, or testicles. The purpose of this ...
View Page